Invesco’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-57,337
| Closed | -$2.34M | – | 3916 |
|
|
2024
Q2 | $2.34M | Buy |
57,337
+17,993
| +46% | +$736K | ﹤0.01% | 2518 |
|
|
2024
Q1 | $1.66M | Buy |
39,344
+8,830
| +29% | +$373K | ﹤0.01% | 2744 |
|
|
2023
Q4 | $1.29M | Sell |
30,514
-1,494
| -5% | -$63.3K | ﹤0.01% | 2777 |
|
|
2023
Q3 | $699K | Sell |
32,008
-366
| -1% | -$7.99K | ﹤0.01% | 3025 |
|
|
2023
Q2 | $1.03M | Buy |
32,374
+458
| +1% | +$14.6K | ﹤0.01% | 2870 |
|
|
2023
Q1 | $778K | Buy |
31,916
+1,263
| +4% | +$30.8K | ﹤0.01% | 3011 |
|
|
2022
Q4 | $967K | Buy |
30,653
+7,875
| +35% | +$248K | ﹤0.01% | 2937 |
|
|
2022
Q3 | $643K | Buy |
22,778
+1,654
| +8% | +$46.7K | ﹤0.01% | 3100 |
|
|
2022
Q2 | $558K | Buy |
21,124
+3,724
| +21% | +$98.4K | ﹤0.01% | 3258 |
|
|
2022
Q1 | $610K | Sell |
17,400
-344
| -2% | -$12.1K | ﹤0.01% | 3264 |
|
|
2021
Q4 | $575K | Sell |
17,744
-337,144
| -95% | -$10.9M | ﹤0.01% | 3294 |
|
|
2021
Q3 | $10.5M | Buy |
354,888
+342,534
| +2,773% | +$10.1M | ﹤0.01% | 1977 |
|
|
2021
Q2 | $317K | Buy |
+12,354
| New | +$317K | ﹤0.01% | 3579 |
|